Zhu, Chunni

A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice

Chesselet, M.-F., Richter, F., Zhu, C., Magen, I., Watson, M. B., & Subramaniam, S. R. (2012) · Neurotherapeutics

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 346

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

Zhang, Y., Calon, F., Zhu, C., Boado, R. J., & Pardridge, W. M. (2003) · Human Gene Therapy

RNA Interference and Gene DeliveryParkinson's Disease Mechanisms and Treatments

Cited by 194

Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease

Lerner, R. P., Trejo Martinez, L. D. C. G., Zhu, C., Chesselet, M.-F., & Hickey, M. A. (2012) · Brain Research Bulletin

Genetic Neurodegenerative DiseasesGenetics and Neurodevelopmental Disorders

Cited by 51